Preparing for genomic medicine: A real world demonstration of health system change

npj Genomic Medicine

Volumn 2, Issue 1, 2017, Pages

  Gaff, Clara L ^a,b   Winship, Ingrid M ^b,c   Forrest, Susan M ^d   Hansen, David P ^e   Clark, Julian ^f   Waring, Paul M ^b   South, Mike ^b,g,h   Sinclair, Andrew H ^b,h  

^a Melbourne Genomics Health Alliance   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d Australian Genome Research Facility Ltd   (Australia)

^e CSIRO   (Australia)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026872497     PISSN: None     EISSN: 20567944     Source Type: Journal    
DOI: 10.1038/s41525-017-0017-4     Document Type: Review

References (39)

1. Manyika, A. et al. Disruptive Technologies: Advances that will transform life, business and the global economy. (McKinsey Global Institute, 2013).
2. Manolio, T. A. et al. Global implementation of genomic medicine: we are not alone. Sci. Transl. Med. 7, 290ps213 (2015).
3. Addie, S., Olson, S. & Beachy, S. H. Applying an implementation science approach to genomic medicine. Workshop Summ. (National Academies Press (US), 2016).
4. Ginsburg, G. S. Realizing the opportunities of genomics in health care. JAMA 309, 1463-1464 (2013).
5. Ginsburg, G. Medical genomics: gather and use genetic data in health care. Nature 508, 451-453 (2014).
6. Braithwaite, J. Clay-Williams, R. Nugus, P., Plumb, J. Healthcare as a complex adaptive system. Resilient Health Care 57-76 (Ashgate Publishing, 2013).
7. Boycott, K. M., Vanstone, M. R., Bulman, D. E. & MacKenzie, A. E. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 14, 681-691 (2013).
8. Sawyer, S. L. et al. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care. Clin. Genet. 89, 275-284 (2016).
9. Global Alliance for Genomics & Health. A federated ecosystem for sharing genomic, clinical data. Science 352, 1278-1280 (2016).
10. Hamilton, A. B. et al. Factors influencing organizational adoption and implementation of clinical genetic services. Genet. Med. 16, 238-245 (2014).
11. Suchman, E. Evaluative Research: Principles and Practice in Public Service and Social Action Programs. (Russell Sage Foundation, 1967).
12. Stark, Z. et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet. Med. 18, 1090-1096 (2016).
13. Stark, Z. et al. Prospective comparison of the cost-effectiveness of clinical whole exome sequencing to usual care overwhelmingly supports early use and reimbursement. Genet. Med. doi:10.1038/gim.2016.221 (2017).
14. Tan, T., et al. Diagnostic impact and cost-effectiveness of exome sequencing for ambulant children with suspected monogenic conditions. JAMA Paediatr. Accepted 3/6/2017 (2017).
15. Walsh, M. et al. Peripheral neuropathy: gene panel or whole exome? Annals Clinical and Translational Neurology. Accepted 3/15/2017 (2017).
16. Perucca, P. et al. Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy. Epilepsy Res. 131, 1-8. doi:10.1016/j.eplepsyres. 2017.02.001 (2017)
17. Australian Bureau of Statistics. Australian Demographic Statistics 2016 (Australian Bureau of Statistics, 2017).
18. Royal Australasian College of Pathologists. Report of the RCPA genetic testing survey 2011. (Royal Australasian College of Pathologists, 2012).
19. Leavitt, J., Mason, D. & Whelan, E.-W. Political Analysis and Strategies in Policy and Politics in Nursing and Healthcare (eds D. H. Mason, J. K. Leavitt, & M. W. Chaffee) 65-76 (Elsevier Saunders, 2013).
20. Funnell, S. C. & Rogers, P. J. Purposeful program theory: effective use of theories of change and logic models. (Jossey-Bass, 2011).
21. Yang, Y. et al. Molecular findings among patients referred for clinical wholeexome sequencing. JAMA 312, 1870-1879 (2014).
22. Wright, C. F. et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 385: 1305-1314, doi:10.1016/s0140-6736(14)61705-0 (2014).
23. Payne, K., McAllister, M. & Davies, L. M. Valuing the economic benefits of complex interventions: when maximising health is not sufficient. Health Econ. 22, 258-271 (2013).
24. Craig, P. et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. Br. Med. J. 337, 979-983 (2008).
25. Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M. & Stetler, C. Effectivenessimplementation hybrid designs combining elements of clinical effectiveness and Implementation research to enhance public health impact. Med. Care 50, 217-226 (2012).
26. Soden, S. E. et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci. Transl. Med. 6, 265ra168 (2014).
27. Willig, L. K. et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir. Med. 3, 377-387 (2015).
28. Daoud, H. et al. Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit. Can. Med. Assoc. J. 188, E254-E260 (2016).
29. Consumer Health Forum of Australia. What is the MBS https://chf.org.au/ publications/what-mbs (2010).
30. Christensen, K. D. et al. Are physicians prepared for whole genome sequencing? a qualitative analysis. Clin. Genet. 89, 228-234 (2016).
31. Guttmacher, A. E., Porteous, M. E. & McInerney, J. D. Educating health-care professionals about genetics and genomics. Nat. Rev. Genet. 8, 151-157 (2007).
32. Bennett, C. L., Burke, S. E., Burton, H. & Farndon, P. A. A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England. BMC Health Serv. Res. 10, 125 (2010).
33. Michie, S., van Stralen, M. M. & West, R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement. Sci. 6, 42 (2011).
34. Michie, S., Atkins, L. & West, R. The behaviour change wheel. A guide to designing interventions. (Silverback publishing, 2014).
35. Bowdin, S. et al. Recommendations for the integration of genomics into clinical practice. Genet. Med. 18, 1075-1084 (2016).
36. Herr, T. M. et al. Practical considerations in genomic decision support: the eMERGE experience. J. Pathol. Inform. 6, 50 (2015).
37. Chadwick R. C. B., Chalmers D., Clarke A., Clayton E. W., Liu E., Lysaght T., Mulvihill J. J., Winslett M. Imagined futures: capturing the benefits of genome sequencing for society. (Human Genome Organisation, 2013).
38. Sadedin, S. P. et al. Cpipe: a shared variant detection pipeline designed for diagnostic settings. Genome Med. 7, 1-10 (2015).
39. Manolio, T. A. et al. Implementing genomic medicine in the clinic: the future is here. Genet. Med. 15, 258-267 (2013).